References
- Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008; 21: 606–625.
- Pfaller MA, Diekema DJ, Jones RN, . International surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the sentry antimicrobial surveillance program. J Clin Microbiol 2001; 39: 3254–3259.
- Almirante B, Rodríguez D, Cuenca-Estrella M, . Epidemiology, risk factors, and prognosis of Candida parapsilosis bloodstream infections: case-control population-based surveillance study of patients in Barcelona, Spain, from 2002 to 2003. J Clin Microbiol 2006; 44: 1681–1685.
- Messer SA, Jones RN, Fritsche TR. International surveillance of Candida spp. and Aspergillus spp.: report from the sentry antimicrobial surveillance program (2003). J Clin Microbiol 2006; 44: 1782–1787.
- Horasan ES, Ersoz G, Goksu M, . Increase in Candida parapsilosis fungemia in critical care units: a 6-years study. Mycopathologia 2010; 170: 263–268.
- Pfaller MA, Diekema DJ. Epidemiology of invasive candidiasis: a persistent public health problem. Clin Microbiol Rev 2007; 20: 133–163.
- van Asbeck EC, Huang YC, Markham AN, Clemons KV, Stevens DA. Candida parapsilosis fungemia in neonates: genotyping results suggest healthcare workers hands as source, and review of published studies. Mycopathologia 2007; 164: 287–293.
- Tavanti A, Davidson AD, Gow NA, Maiden MC, Odds FC. Candida orthopsilosis and Candida metapsilosis spp. nov. to replace Candida parapsilosis groups II and III. J Clin Microbiol 2005; 43: 284–292.
- González GM, Elizondo M, Ayala J. Trends in species distribution and susceptibility of bloodstream isolates of Candida collected in Monterrey, Mexico, to seven antifungal agents: results of a 3-year (2004 to 2007) surveillance study. J Clin Microbiol 2008; 46: 2902–2905.
- Treviño-Rangel R, Garza-González E, González JG, . Molecular characterization and antifungal susceptibility of the Candida parapsilosis species complex of clinical isolates from Monterrey, Mexico. Med Mycol 2012 (in press; PMID: 22493945, Date: Apr 12, 2012).
- Schaller M, Borelli C, Korting HC, Hube B. Hydrolytic enzymes as virulence factors of Candida albicans. Mycoses 2005; 48: 365–377.
- Chakrabarti A, Nayak N, Talwar P. In vitro proteinase production by Candida species. Mycopathologia 1991; 114: 163–168.
- Price MF, Wilkinson ID, Gentry LO. Plate method for detection of phospholipase activity in Candida albicans. Sabouraudia 1982; 20: 7–14.
- Ghannoum MA. Potential role of phospholipases in virulence and fungal pathogenesis. Clin Microbiol Rev 2000; 13: 122–143.
- Kumar CP, Menon T, Sundararajan T, . Esterase activity of Candida species isolated from immunocompromised hosts. Rev Iberoam Micol 2006; 23: 101–103.
- Slifkin M. Tween 80 opacity test responses of various Candida species. J Clin Microbiol 2000; 38: 4626–4628.
- Luo G, Samaranayake LP, Yau JY. Candida species exhibit differential in vitro hemolytic activities. J Clin Microbiol 2001; 39: 2971–2974.
- Koga-Ito CY, Lyon JP, Vidotto V, de Resende MA. Virulence factors and antifungal susceptibility of Candida albicans isolates from oral candidosis patients and control individuals. Mycopathologia 2006; 161: 219–223.
- Ruchel R, de Bernardis F, Ray TL, Sullivan PA, Cole GT. Candida acid proteinases. J Med Vet Mycol. 1992; 30 (Suppl. 1): 123–132.
- Dagdeviren M, Cerikcioglu N, Karavus M. Acid proteinase, phospholipase and adherence properties of Candida parapsilosis strains isolated from clinical specimens of hospitalised patients. Mycoses 2005; 48: 321–326.
- França EJ, Furlaneto-Maia L, Quesada RM, . Haemolytic and proteinase activities in clinical isolates of Candida parapsilosis and Candida tropicalis with reference to the isolation anatomic site. Mycoses 2011; 54: 44–51.
- Pugh D, Cawson RA. The cytochemical localization of phospholipase in Candida albicans infecting the chick chorio-allantoic membrane. Sabouraudia 1977; 15: 29–35.
- Barrett-Bee K, Hayes Y, Wilson RG, Ryley JF. A comparison of phospholipase activity, cellular adherence and pathogenicity of yeasts. J Gen Microbiol 1985; 131: 1217–1221.
- Jayatilake JA, Samaranayake YH, Samaranayake LP. An ultrastructural and a cytochemical study of candidal invasion of reconstituted human oral epithelium. J Oral Pathol Med 2005; 34: 240–246.
- Filler SG, Ibe BO, Luckett PM, Raj JU, Edwards JE Jr. Candida albicans stimulates endothelial cell eicosanoid production. J Infect Dis 1991; 164: 928–935.
- Shimizu MT, Almeida NQ, Fantinato V, Unterkircher CS. Studies on hyaluronidase, chondroitin sulphatase, proteinase and phospholipase secreted by Candida species. Mycoses 1996; 39: 161–167.
- Kantarcioglu AS, Yucel A. Phospholipase and protease activities in clinical Candida isolates with reference to the sources of strains. Mycoses 2002; 45: 160–165.
- Yücesoy M, Marol S. Determination of esterase activity of Candida varieties. Mikrobiyol Bul 2003; 37: 59–63.
- Ge YP, Lu GX, Shen YN, Liu WD. In vitro evaluation of phospholipase, proteinase, and esterase activities of Candida parapsilosis and Candida metapsilosis. Mycopathologia 2011; 172: 429–438.
- Manns JM, Mosser DM, Buckley HR. Production of a hemolytic factor by Candida albicans. Infect Immun 1994; 62: 5154–5156.